bluebird bio Inc (NASDAQ:BLUE)

206.05
Delayed Data
As of Feb 23
 +4.85 / +2.41%
Today’s Change
74.40
Today|||52-Week Range
222.03
+15.69%
Year-to-Date
Recession is Coming! Not
Feb 23 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close201.20
Today’s open203.65
Day’s range199.65 - 206.35
Volume424,838
Average volume (3 months)903,895
Market cap$10.3B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-9.05%
Earnings growth (this year)--
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)+475.58%
P/E ratioNM
Price/Sales218.86
Price/Book6.27

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc+0.44+0.42%
NBIXNeurocrine Bioscienc...-1.15-1.35%
EXASExact Sciences Corp-2.62-5.82%
TECHBio-Techne Corp+2.49+1.78%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$35.4M
Annual profit (last year)-$335.6M
Net profit margin-947.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts